Related references
Note: Only part of the references are listed.Association of CYP2B6, CYP3A5, and CYP2C19 Genetic Polymorphisms With Sibutramine Pharmacokinetics in Healthy Korean Subjects
K. A. Kim et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Mechanism-Based Inhibition of Human Cytochrome P450 2B6 by Ticlopidine, Clopidogrel, and the Thiolactone Metabolite of Prasugrel
Yumi Nishiya et al.
DRUG METABOLISM AND DISPOSITION (2009)
Clopidogrel Inhibits CYP2C19-Dependent Hydroxylation of Omeprazole Related to CYP2C19 Genetic Polymorphisms
B. L. Chen et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Comparison of mechanism-based inhibition of human cytochrome P450 2C19 by ticlopidine, clopidogrel, and prasugrel
Y. Nishiya et al.
XENOBIOTICA (2009)
Sibutramine-associated QT interval prolongation and cardiac arrest
David Ernest et al.
ANNALS OF PHARMACOTHERAPY (2008)
Cytochrome P450 2B6 catalyzes the formation of pharmacologically active sibutramine (N-{1-[1-(4chlorophenyl) cyclobutyl]-3-methylbutyl}-N,N-dimethylamine) metabolites in human liver microsomes
Soo Kyung Bae et al.
DRUG METABOLISM AND DISPOSITION (2008)
Comparison of Human Cytochrome P450 Inhibition by the Thienopyridines Prasugrel, Clopidogrel, and Ticlopidine
Katsunobu Hagihara et al.
DRUG METABOLISM AND PHARMACOKINETICS (2008)
Sibutramine-associated adverse effects: a practical guide for its safe use
M. Florentin et al.
OBESITY REVIEWS (2008)
Genetic polymorphisms of CYP2B6 affect the pharmacokinetics/pharmacodynamics of cyclophosphamide in Japanese cancer patients
Miki Nakajima et al.
PHARMACOGENETICS AND GENOMICS (2007)
Metabolite profile of sibutramine in human urine:: a liquid chromatography-electrospray ionization mass spectrometric study
Marek Link et al.
JOURNAL OF MASS SPECTROMETRY (2006)
QT interval prolongation associated with sibutramine treatment
M Harrison-Woolrych et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
A common novel CTP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants
SC Sim et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Effect of clopidogrel and ticlopidine on cytochrome P4502B6 activity as measured by bupropion hydroxylation
M Turpeinen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases, and glucuronyl transferases in human: An in vitro study
RS Obach et al.
DRUG METABOLISM AND DISPOSITION (2005)
Potent mechanism-based inhibition of human CYP2B6 by clopidogrel and ticlopidine
T Richter et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
The discovery and status of sibutramine as an anti-obesity drug
CA Luque et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Enantioselective behavioral effects of sibutramine metabolites
SD Glick et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Share Paper
